Progesterone Levels Associated with Proteinuria in Male Diabetes Mellitus Patients: A Cross-sectional Retrospective Study

Overview

Journal J Diabetes Investig

Specialty Endocrinology

Date 2023 Feb 24

PMID 36824009

Authors

Chuanfeng Liu

Yajing Huang

Yuzhao Liu

Yu Xin

Lili Xu

Ruizhi Zhou

Zepeng Mu

Yi Junling

Xiwen Wang

Yangang Wang

Affiliations

Soon will be listed here.

Abstract

Introduction: The relationship between progesterone (P) and diabetic nephropathy (DKD) is unclear. Herein, we investigated the relationship between progesterone and DKD in men and postmenopausal women with type 2 diabetes mellitus. MATERIALS AND METHODS: We recruited 3,556 male and postmenopausal female patients and obtained the dominance ratio (OR) and corresponding 95% confidence intervals (CIs) associated with progesterone by logistic regression analysis after adjusting for potentially confounding variants.

Results: We found that progesterone levels were significantly lower in the massive proteinuria and microproteinuria groups compared with the non-DKD group for male patients. Also, microproteinuria and massive proteinuria prevalence were higher in the first (lowest) progesterone quartile than in the second to fourth quartiles. After adjusting for confounders, compared with the first (lowest) progesterone quartile group, the OR for the second to fourth quartiles in the male microproteinuria subgroup, were: Q2: 0.846 (95% CI: 0.581-1.233, P = 0.385); Q3: 0.667 (95% CI: 0.45-0988, P = 0.044); Q4: 0.597 (95% CI: 0.393-0.907, P = 0.016). In the male massive proteinuria subgroup, the OR for the third quartile group was 0.418 (95% CI: 0.201-0.867, P = 0.019). In contrast, no significant association was detected between progesterone and DKD prevalence in the female group.

Conclusions: Progesterone levels were negatively associated with DKD incidence in hospitalized male patients with type 2 diabetes mellitus.

References

Wang M, Wang Z, Chen Y, Dong Y . Kidney Damage Caused by Obesity and Its Feasible Treatment Drugs. Int J Mol Sci. 2022; 23(2). PMC: 8775419. DOI: 10.3390/ijms23020747. View

Huang Y, Xu D, Long J, Shi Y, Zhang L, Wang H . Spectrum of chronic kidney disease in China: A national study based on hospitalized patients from 2010 to 2015. Nephrology (Carlton). 2018; 24(7):725-736. DOI: 10.1111/nep.13489. View

Kautzky-Willer A, Harreiter J, Pacini G . Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus. Endocr Rev. 2016; 37(3):278-316. PMC: 4890267. DOI: 10.1210/er.2015-1137. View

Jiang C, Tsao C, Lee Y . Vitamin C attenuates predisposition to high-fat diet-induced metabolic dysregulation in GLUT10-deficient mouse model. Genes Nutr. 2022; 17(1):10. PMC: 9288715. DOI: 10.1186/s12263-022-00713-y. View

Wang L, Mao Z, Liu X, Wei D, Liu P, Nie L . Combined effects of progesterone and SOCS3 DNA methylation on T2DM: a case-control study. Clin Epigenetics. 2021; 13(1):181. PMC: 8474856. DOI: 10.1186/s13148-021-01172-9. View

Zhao J, Schooling C . The role of testosterone in chronic kidney disease and kidney function in men and women: a bi-directional Mendelian randomization study in the UK Biobank. BMC Med. 2020; 18(1):122. PMC: 7271464. DOI: 10.1186/s12916-020-01594-x. View

Cefalu W, Buse J, Tuomilehto J, Fleming G, Ferrannini E, Gerstein H . Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum. Diabetes Care. 2016; 39(7):1186-201. PMC: 4915559. DOI: 10.2337/dc16-0873. View

Onk D, Alper Onk O, Turkmen K, Erol H, Akarsu Ayazoglu T, Keles O . Melatonin Attenuates Contrast-Induced Nephropathy in Diabetic Rats: The Role of Interleukin-33 and Oxidative Stress. Mediators Inflamm. 2016; 2016:9050828. PMC: 4775802. DOI: 10.1155/2016/9050828. View

Mokhtari S, Sistani Karampour N, Shams M, Dehpour A, Hasanvand A . Protective assessment of progesterone and its receptor on experimental diabetic neuropathy: Antioxidant and anti-inflammatory effects. Fundam Clin Pharmacol. 2022; 37(2):287-295. DOI: 10.1111/fcp.12839. View

10.

Holley J . The hypothalamic-pituitary axis in men and women with chronic kidney disease. Adv Chronic Kidney Dis. 2004; 11(4):337-41. View

11.

Zhou Y, Shen L, Dong B, Liu C, Lv W, Chi J . Elevated circulating luteinizing hormone levels are associated with diabetic macroalbuminuria in Chinese men and postmenopausal women: A cross-sectional study. J Diabetes. 2020; 12(11):819-833. DOI: 10.1111/1753-0407.13073. View

12.

Zheng W, Guo J, Liu Z . Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: an epigenetic perspective. Clin Epigenetics. 2021; 13(1):87. PMC: 8061201. DOI: 10.1186/s13148-021-01079-5. View

13.

Cermenati G, Giatti S, Audano M, Pesaresi M, Spezzano R, Caruso D . Diabetes alters myelin lipid profile in rat cerebral cortex: Protective effects of dihydroprogesterone. J Steroid Biochem Mol Biol. 2017; 168:60-70. DOI: 10.1016/j.jsbmb.2017.02.002. View

14.

Recalde G, Moreno-Sosa T, Yudica F, Quintero C, Sanchez M, Jahn G . Contribution of sex steroids and prolactin to the modulation of T and B cells during autoimmunity. Autoimmun Rev. 2018; 17(5):504-512. DOI: 10.1016/j.autrev.2018.03.006. View

15.

Wang C, Zhang W, Wang Y, Wan H, Chen Y, Xia F . Novel associations between sex hormones and diabetic vascular complications in men and postmenopausal women: a cross-sectional study. Cardiovasc Diabetol. 2019; 18(1):97. PMC: 6668151. DOI: 10.1186/s12933-019-0901-6. View

16.

Komukai K, Mochizuki S, Yoshimura M . Gender and the renin-angiotensin-aldosterone system. Fundam Clin Pharmacol. 2010; 24(6):687-98. DOI: 10.1111/j.1472-8206.2010.00854.x. View

17.

Kadhim H, Ismail S, Hussein K, Bakir I, Salih Sahib A, Khalaf B . Effects of melatonin and zinc on lipid profile and renal function in type 2 diabetic patients poorly controlled with metformin. J Pineal Res. 2006; 41(2):189-93. DOI: 10.1111/j.1600-079X.2006.00353.x. View

18.

Radcliffe N, Seah J, Clarke M, MacIsaac R, Jerums G, Ekinci E . Clinical predictive factors in diabetic kidney disease progression. J Diabetes Investig. 2016; 8(1):6-18. PMC: 5217935. DOI: 10.1111/jdi.12533. View

19.

Mujais S, Nora N, Chen Y . Regulation of the renal Na:K pump: role of progesterone. J Am Soc Nephrol. 1993; 3(8):1488-95. DOI: 10.1681/ASN.V381488. View

20.

Sandhi J, Singh J, Kaur T, Ghuman S, Singh A . Involvement of progesterone receptors in ascorbic acid-mediated protection against ischemia-reperfusion-induced acute kidney injury. J Surg Res. 2013; 187(1):278-88. DOI: 10.1016/j.jss.2013.10.025. View